Research & Diagnostic Antibodies LLC - Product Pipeline Analysis, 2019 Update
June 2019
26
About the Report
About the Report
Summary
Research & Diagnostic Antibodies LLC (R&D Ab) is a provider of antibodies, immunoassays, and assay kits. The company's products include monoclonal antibodies, histochemical grade antibodies, immunoprecipitating antibodies, botox and botox substrate antibodies and kits, dopamine receptor antibodies, leptin antibodies, and muscarinic receptor antibodies and kits. It also provides nicotinic receptor antibodies and kits, nitric oxide synthase antibodies and kits, opioid receptor antibodies and kits slurp receptor antibodies, thrombopoietin antibodies and kits, immunofluorescent assay kits, and western reagents. The company's services include monoclonal antibody development and production, immunoassay development services, ELISA characterization of antibodies; conjugation of peptides, haptens and enzymes, and antibody purification. R&D Ab is headquartered in Las Vegas, Nevada, the US.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Research & Diagnostic Antibodies LLC
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Products
Products
Research & Diagnostic Antibodies LLC, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies
Companies
Marker Gene Technologies Inc
New England Biolabs Inc
Signalway Antibody Co Ltd
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Research & Diagnostic Antibodies LLC Company Overview
Research & Diagnostic Antibodies LLC Company Snapshot
Research & Diagnostic Antibodies LLC Pipeline Products and Ongoing Clinical Trials Overview
Research & Diagnostic Antibodies LLC-Pipeline Analysis Overview
Research & Diagnostic Antibodies LLC-Key Facts
Research & Diagnostic Antibodies LLC-Major Products and Services
Research & Diagnostic Antibodies LLC Pipeline Products by Development Stage
Research & Diagnostic Antibodies LLC Pipeline Products Overview
Clinical Laboratory Auto-analyzer Test-Sepsis
Clinical Laboratory Auto-analyzer Test-Sepsis Product Overview
Diagnostic Test-Rheumatoid Arthritis
Diagnostic Test-Rheumatoid Arthritis Product Overview
Diagnostic Test-Crohn's Disease
Diagnostic Test-Crohn's Disease Product Overview
Diagnostic Test-Transplant And Graft Rejection
Diagnostic Test-Transplant And Graft Rejection Product Overview
Diagnostic Test-Ulcerative Colitis
Diagnostic Test-Ulcerative Colitis Product Overview
Flow Cytometry Clinical Test-Sepsis
Flow Cytometry Clinical Test-Sepsis Product Overview
Point-of-Care Device-Sepsis And Severe Sepsis
Point-of-Care Device-Sepsis And Severe Sepsis Product Overview
Research & Diagnostic Antibodies LLC-Key Competitors
Research & Diagnostic Antibodies LLC-Key Employees
Research & Diagnostic Antibodies LLC-Locations And Subsidiaries
Head Office
Recent Developments
Research & Diagnostic Antibodies LLC, Recent Developments
Nov 12, 2015: Research & Diagnostic Antibodies Announces the Launch of the PliNOSa Assay Kit, a First-In-Class CE Marked IVD Test for the Onset of Sepsis
Jul 26, 2012: Research & Diagnostic Antibodies Receives Notice of Allowance for Second Key Sepsis Diagnostic Patent in Japan
Apr 21, 2010: R&D Antibodies Gets USD 2.6 Million Grant From NIGMS
Oct 27, 2009: Research & Diagnostic Antibodies Receives Allowance for Key SIRS/Sepsis Diagnostic Patent in Europe
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
Research & Diagnostic Antibodies LLC Pipeline Products by Equipment Type
Research & Diagnostic Antibodies LLC Pipeline Products by Development Stage
List of Table
List of Tables
Research & Diagnostic Antibodies LLC Pipeline Products and Ongoing Clinical Trials Overview
Research & Diagnostic Antibodies LLC Pipeline Products by Equipment Type
Research & Diagnostic Antibodies LLC Pipeline Products by Indication
Research & Diagnostic Antibodies LLC, Key Facts
Research & Diagnostic Antibodies LLC, Major Products and Services
Research & Diagnostic Antibodies LLC Number of Pipeline Products by Development Stage
Research & Diagnostic Antibodies LLC Pipeline Products Summary by Development Stage
Clinical Laboratory Auto-analyzer Test-Sepsis-Product Status
Clinical Laboratory Auto-analyzer Test-Sepsis-Product Description
Diagnostic Test-Rheumatoid Arthritis-Product Status
Diagnostic Test-Rheumatoid Arthritis-Product Description
Diagnostic Test-Crohn's Disease-Product Status
Diagnostic Test-Crohn's Disease-Product Description
Diagnostic Test-Transplant And Graft Rejection-Product Status
Diagnostic Test-Transplant And Graft Rejection-Product Description
Diagnostic Test-Ulcerative Colitis-Product Status
Diagnostic Test-Ulcerative Colitis-Product Description
Flow Cytometry Clinical Test-Sepsis-Product Status
Flow Cytometry Clinical Test-Sepsis-Product Description
Point-of-Care Device-Sepsis And Severe Sepsis-Product Status
Point-of-Care Device-Sepsis And Severe Sepsis-Product Description
Research & Diagnostic Antibodies LLC, Key Employees
Glossary
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.